Sponsor:Charite University, Berlin, GermanyBrief Summary: This is an international, multicenter, randomized controlled trial of an internet-based CBT intervention for depression…
Sponsor:Riley Bove, MDBrief Summary: The primary goal of this study is to assess the efficacy of bazedoxifene (BZA) as remyelinating…
Sponsor:SanofiBrief Summary: Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive…
Sponsor:SanofiBrief Summary: Primary Objective: To evaluate any potential increase in the risk of major birth defects, in the first year…
Sponsor:Hoffmann-La RocheBrief Summary: This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants…
Sponsor:University of California, San FranciscoBrief Summary: Newly diagnosed relapsing multiple sclerosis (MS) and high risk clinically isolated syndrome (CIS) patients…
Sponsor:Johns Hopkins UniversityBrief Summary: FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal…
Sponsor:University of California, San FranciscoBrief Summary: Many people with MS report sleep disturbances. However, objective data on sleep quality in…
Sponsor:University of California, San FranciscoBrief Summary: The goal is to investigate the effects of non-invasive transcranial electrical stimulation on cognition…
Sponsor:Hoffmann-La RocheBrief Summary: This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple…
